Melanoma Molecular Maps Projects

Padova

Scientific Advisory Board



- Coordinator: Simone Mocellin (University of Padova, Padova, Italy) simone.mocellin@unipd.it

- Paolo Ascierto (National Cancer Institute, Naples, Italy)

- Margit Balàzs (University of Debrecen, Debrecen, Hungary)

- Menashe Bar-Eli (University of Texas M.D. Anderson Cancer Center, Houston, USA)

- Marianne Berwick (University of New Mexico, Albuquerque, USA)

- Anja K. Bosserhoff (University of Regensburg, Regensburg, Germany)

- Vincenzo Bronte (University of Padova, Padova, Italy)

- Paul B. Chapman (Memorial Sloan Kettering Cancer Center, New York, USA)

- Bertil Damato (Royal Liverpool University Hospital, Liverpool, UK)

- Alexander M.M. Eggermont (Erasmus University MC, Rotterdam, The Netherlands)

- Christine Falk (University of Heidelberg, Heidelberg, Germany)

- Paul T. Finger (The Eye Cancer Center, New York, USA)

- David E. Fisher (Massachusetts General Hospital, Boston, USA)

- Claus Garbe (University Medical Center, Tuebingen, Germany)

- Elizabeth Grimm (University of Texas M.D. Anderson Cancer Center, Houston, USA)

- Allan C. Halpern (Memorial Sloan Kettering Cancer Center, New York, USA)

- Axel Hauschild (University of Kiel, Kiel, Germany)

- Meenhard Herlyn (The Wistar Institute, Philadelphia, USA)

- Peter Hersey (University of Newcastle, Newcastle, Australia)

- Dave Hoon (John Wayne Cancer Institute, Santa Monica, USA)

- Patrick Hwu (The University of Texas, M.D. Anderson Cancer Center, Houston, USA)

- Mohammed Kashani-Sabet (University of California-San Francisco, San Francisco, USA)

- Richard Kefford (University of Sydney at Westmead Hospital, Westmead, Australia)

- John M. Kirkwood (University of Pittsburgh, Pittsburgh, USA)

- Sewa S. Legha (St. Luke's Episcopal Hospital, Baylor College of Medicine, Houston, USA)

- Wolfgang Leitner (National Institutes of Health, Bethesda, USA)

- Gang Li (University of British Columbia, Vancouver, Canada)

- Jose I. Mayordomo (University Hospital, Zaragoza, Spain)

- Francesco M. Marincola (National Institutes of Health, Bethesda, USA)

- Estela E. Medrano (Baylor College of Medicine, Houston, USA)

- Glenn Merlino (National Cancer Institute, NIH, Bethesda, USA)

- George Millington (Norfolk and Norwich University Hospital, Norwich, UK)

- Julia Newton Bishop (University of Leeds, Leeds, UK)

- Donato Nitti (University of Padova, Padova, Italy)

- Steven O'Day (The Angeles Clinic and Research Institute, Santa Monica, USA)

- Kartikeya Pant (Massachusetts Institute of Technology, Cambridge, USA)

- Nives Pecina-Slaus (University of Zagreb, Zagreb, Croatia)

- Maurizio Provenzano (University Hospital of Zurich, Zurich, Switzerland)

- Adam Riker (University of South Alabama, Mobile, USA)

- David L. Rimm (University of Yale, New Haven, USA)

- Syed A. R. Rizvi (Jawaharlal Nehru Medical College, Aligarh, India)

- Carlo R. Rossi (University of Padova, Padova, Italy)

- Dirk Schadendorf (University of Essen, Essen, Germany)

- Henrik Schmidt (Aarhus University Hospital, Aarhus, Denmark)

- Richard Scolyer (University of Sydney, Sydney, Australia)

- Keiran Smalley (The Moffitt Cancer Center and Research Institute, Tampa, USA)

- Andrew J. Spillane (University of Sydney, Sydney, Australia)

- Ignazio Stanganelli (Skin Cancer Unit IRST - Meldola and Ospedale Niguarda - Milan, Italy)

- Alexander J. Stratigos (University of Athens, Athens, Greece)

- Alessandro Testori (Istituto Europeo di Oncologia, Milan, Italy)

- John F. Thompson (Sydney Melanoma Unit, Sydney, Australia)

- Ena Wang (National Institutes of Health, Bethesda, USA)

- Jeffrey Weber (Moffitt Cancer Center, University of South Florida, Tampa, USA)

- Ashani Weeraratna (National Institutes of Health, Baltimore, USA)

- Howard Young (National Cancer Institute, Frederick, USA)

Search the site


Risk Assessment Tools

TNM Staging System | Total Dermoscopy Score | Thin Melanoma Prognosis |


Melanoma News


NCBI's Disclaimer and Copyright notice